Los puntos clave no están disponibles para este artículo en este momento.
After introduction of PCV in 2009, we have observed a significantly decreased number of pneumococcal isolates in the upper respiratory tract, a shift to non-PHiD-CV10 serotypes, and a reduction of complicated AOM. Our findings may have implications for future vaccine design.
Littorin et al. (Thu,) studied this question.